Fundz

Tmrw Life Sciences, Inc. reported raising $20 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEFeb 12, 2021

Amount Raised

$20 Million

$20 Million sold, per SEC Form D (first sale Feb 12, 2021)

Round Type

Venture

New YorkBiotechnologyHealthcare

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as TMRW Life Sciences that raised within 45 days of this round, from Fundz verified event records.

  • Endolytix Technology raised $12M on March 26, 2021.
  • Azora Therapeutics, Inc. (DE) raised $291K on March 26, 2021.
  • Enlaza Therapeutics raised $35M on March 25, 2021.
  • Polaris Genomics raised $100K on March 25, 2021.
  • ExThera Medical raised $21M on March 25, 2021.
  • Ariste Medical, LLC raised $56K (Seed) on March 23, 2021.

Who to call at TMRW Life Sciences, and when

A new round usually means TMRW Life Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TMRW Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TMRW Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TMRW Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TMRW Life Sciences

Location

New York, New York, United States

About

TMRW Life Sciences is a fertility technology company that provides safety and transparency to modernize and transform egg and embryo storage. The current system is manual, outdated, and stressful for embryologists and clinicians. Automatization and state-of-the-art technology identify, track and remotely monitor frozen eggs and embryos. TMRW is a scalable solution for overcrowded clinics that have unintentionally become storage facilities since the rise in people seeking fertility treatments. Named Fast Company's #1 Most Innovative Biotech Company in 2022, TMRW is in leading clinics across the US and will soon be available in the UK and Europe.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TMRW Life Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsJeff F., Director of Technology hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for TMRW Life Sciences's next move

See what Strategic adds

TMRW Life Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.